Please login or register first to view this content.
Neurologic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Most With AD, MCI Would Have Been Excluded From Aducanumab Clinical Trials
Less Screen Time After Concussion Tied to Faster Recovery
Intraperitoneal Therapy Gets Orphan Drug Status for Hyperammonemia
Briviact Approval Expanded to Include Younger Patients with Partial-Onset Seizures
Vagus Nerve Stimulation System Approved for Post Stroke Rehabilitation Therapy
Trial Evaluating Ravulizumab for Amyotrophic Lateral Sclerosis Discontinued
Fifteen Headache-Day Threshold Does Not Capture Migraine Burden
Complaint Prompts FDA Action on Use of Purple Patient Bracelets, Wristbands
Oral Myosin Inhibitor Fast Tracked for Becker Muscular Dystrophy
DPP-4i Use May Protect in Alzheimer Dementia With Diabetes
Evidence to Support Suicidality Warning for Newer Antiseizure Meds Lacking
Neck Pain With Migraine Not Necessarily Cervical Dysfunction
Patients Report Memory Problems After Mild COVID-19
Dietary Flavonoids May Lower Odds of Subjective Cognitive Decline
Botox Approval Expanded to Include 8 New Muscles for Upper Limb Spasticity
FDA Needs More Data on Sulopenem for Uncomplicated UTI
Relapse Risk for Psychosis in Dementia Lower With Continued Pimavanserin
Lithium Compared With Newer Therapies as Adjunct to Antidepressants